comparemela.com

Latest Breaking News On - Biopharmaceutical development - Page 1 : comparemela.com

Mesa Laboratories (NASDAQ:MLAB) Shares Down 5%

Mesa Laboratories, Inc. (NASDAQ:MLAB – Get Free Report)’s share price fell 5% on Monday . The stock traded as low as $99.51 and last traded at $99.51. 16,576 shares were traded during trading, a decline of 63% from the average session volume of 44,738 shares. The stock had previously closed at $104.80. Wall Street Analyst […]

Louisiana
United-states
America
Asia-pacific
Entrypoint-capital
Calibration-solutions
Quadrant-capital-group
Nasdaq
Mesa-laboratories-inc
Jump-financial
Biopharmaceutical-development
Pricet-rowe-associates-inc

Mesa Laboratories, Inc. (NASDAQ:MLAB) Shares Purchased by Ranger Investment Management L.P.

Ranger Investment Management L.P. boosted its position in Mesa Laboratories, Inc. (NASDAQ:MLAB – Free Report) by 1.2% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 226,682 shares of the medical instruments supplier’s stock after buying an additional 2,689 shares […]

United-states
America
Asia-pacific
Nasdaq
King-luther-capital-management-corp
Mesa-laboratories-inc
Mesa-laboratories-company-profile
Quadrant-capital-group
Biopharmaceutical-development
Exchange-commission
Calibration-solutions
Comerica-bank

Syngene launches platform for rapid, enhanced protein production

Syngene launches platform for rapid, enhanced protein production
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Switzerland
Swiss
Florianm-wurm
Bristol-myers-squibb
Sridevi-khambhampaty
Manufacturing-services
Merck-kgaa
Syngene-international-ltd
Syngene-international
Excellgene-inc
Amgen
Merck-kga
© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.